Ensysce Biosciences, Inc. (ENSC) Operating cash flow 2018–2025
Ensysce Biosciences, Inc. (ENSC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.8MFY2025 · since FY2018: -$1.2M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | -4.0% |
| FY2024 | -$7.5M | +30.4% |
| FY2023 | -$10.8M | +39.7% |
| FY2022 | -$17.9M | -117.0% |
| FY2021 | -$8.2M | -560.8% |
| FY2020 | -$1.2M | +12.5% |
| FY2019 | -$1.4M | -15.1% |
| FY2018 | -$1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice